Ethylene

Ethylene

SCHEMBL6995455

C=C.CCOC(C)OCC.O=C1CN(CCCCl)S(=O)(=O)c2ccc(Cl)cc21

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.36
CTDSP1 Q9GZU7 1/20 0.35
ADRA1D P25100 5/20 0.34
ADRA1A P35348 5/20 0.34
ADRA1B P35368 4/20 0.34
TP53 P04637 2/20 0.32
MAPT P10636 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
GABRG2 P18507 3/20 0.32
GABRB3 P28472 3/20 0.32
GABRA5 P31644 3/20 0.32
GABRA1 P14867 2/20 0.32
GABRA3 P34903 2/20 0.32
GABRA2 P47869 2/20 0.32
GABRA6 Q16445 2/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32
POLB P06746 1/20 0.32
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6999382 0.92 TDP1 (0.36) TDP1CTDSP1GABRG2GABRB3GABRA5
Ethylene SCHEMBL6994583 0.88 L3MBTL1 (0.43) TDP1CTDSP1ADRA1DADRA1AADRA1B
Ethylene SCHEMBL6996408 0.87 TDP1 (0.50) TDP1CTDSP1MAPTPOLB
SCHEMBL9042668 0.86 TDP1 (0.44) TDP1CTDSP1ADRA1DADRA1AADRA1B
Ethylene SCHEMBL6999766 0.84 TDP1 (0.49) TDP1CTDSP1MAPTPOLB
Ethylene SCHEMBL6994212 0.82 TDP1 (0.37) TDP1CTDSP1
Ethylene SCHEMBL6996875 0.82 CACNA1G (0.41) ADRA1AADRA1BTP53MAPT
Ethylene SCHEMBL6999949 0.80 TDP1 (0.52) TDP1CTDSP1MAPTPOLB
Ethylene SCHEMBL6988936 0.80 ELANE (0.37) TDP1CTDSP1
Ethylene SCHEMBL6996889 0.79 DRD2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
EP-0749967-B1 Substituted benzothiazine derivative SUNTORY LTD (JP) 2003-01-22 EP disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
US-5874429-A ANTIISCHEMIC AGENTS; CEREBROVASCULAR DISORDERS; CIRCULATORY IDSORDERS SUNTORY LIMITED (JP) 1999-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 TDP1 3378/4885CTDSP1 2741/4885ADRA1D 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.